https://www.selleckchem.com/mTOR.html
by VD3 and IGFBP-3 independent Bcl-2 suppression by VD3 treatment in prostate cancer cells. The results could prompt a re-evaluation of VD3 usage in therapy for patients with prostate cancer.An amendment to this paper has been published and can be accessed via the original article. To investigate the resilience of non-local medical workers sent to support local medical workers in treating the outbreak of 2019 novel coronavirus disease (COVID-19). In February 2020, non-local medical workers who had been sent to Wuhan as support staff to respond to t
Like
Comment
Share
